Growth Metrics

Omeros (OMER) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 70.34%
Dec 31, 2025 33.61%
Sep 30, 2025 -43.01%
Jun 30, 2025 -83.54%
Mar 31, 2025 -199.40%
Dec 31, 2024 -630.93%
Sep 30, 2024 -1,005.02%
Jun 30, 2024 -707.50%
Mar 31, 2024 -229.84%
Dec 31, 2023 -129.16%
Sep 30, 2023 69.88%
Jun 30, 2023 162.72%
Mar 31, 2023 1,215.45%
Dec 31, 2022 260.32%
Sep 30, 2022 82.37%
Jun 30, 2022 86.72%
Mar 31, 2022 97.78%
Dec 31, 2021 119.69%
Sep 30, 2021 -200.82%
Jun 30, 2021 -52.72%
Mar 31, 2021 -68.32%
Dec 31, 2020 -10.76%
Sep 30, 2020 37.59%
Jun 30, 2020 -23.79%
Mar 31, 2020 -8.96%
Dec 31, 2019 -8.85%
Sep 30, 2019 -57.21%
Jun 30, 2019 -131.40%
Mar 31, 2019 -314.24%
Dec 31, 2018 -3,459.20%
Sep 30, 2018 -1,066.20%
Jun 30, 2018 -2.64%
Mar 31, 2018 39.28%
Dec 31, 2017 92.49%
Sep 30, 2017 140.45%
Jun 30, 2017 -11.95%
Mar 31, 2017 -18.09%
Dec 31, 2016 -42.74%
Sep 30, 2016 -152.91%
Jun 30, 2016 -717.69%
Mar 31, 2016 -286.50%
Dec 31, 2015 38.50%
Sep 30, 2015 66.14%
Jun 30, 2015 174.75%
Mar 31, 2015 319.15%
Dec 31, 2014 -132.02%
Sep 30, 2014 -11.28%
Jun 30, 2014 13.42%
Mar 31, 2014 132.85%
Dec 31, 2013 -181.49%
Sep 30, 2013 -2,813.78%
Jun 30, 2013 40.32%
Mar 31, 2013 -25.08%
Dec 31, 2012 -17.59%
Sep 30, 2012 -120.11%
Jun 30, 2012 -305.06%
Dec 31, 2011 -127.13%